Rika Rachmalina | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Rika Rachmalina
National Research and Innovation Agency, Indonesia

Rika Rachmalina
Affiliation National Research and Innovation Agency
Country Indonesia
Scopus Id 57202159129
Documents 12
Citations 148
h-index 7
Subject Area Medicine
Event International Popular Scientist Awards
Orcid 0000-0002-8290-3208

Rika Rachmalina is a researcher affiliated with the National Research and Innovation Agency of Indonesia whose documented scholarly work is situated within medicine and public health, with particular relevance to nutrition, child health, maternal health, health-care access, and population-level health disparities. Her publication record includes collaborative research addressing child malnutrition, minimum acceptable diet practices, nutritional and socioeconomic disparities, hemoglobin-related characteristics, alcohol consumption, and pregnancy complications in Indonesia. These themes provide a coherent basis for consideration under the Best Researcher Award at the International Popular Scientist Awards.

Abstract

Rika Rachmalina’s research profile reflects sustained engagement with population health and medical research in the Indonesian context. Her documented publications examine determinants of child nutrition, malnutrition during the COVID-19 pandemic, geographic and socioeconomic disparities in child undernutrition, dietary and biochemical characteristics of the Indonesian population, alcohol consumption, and barriers to health-care access associated with pregnancy complications. The reported Scopus profile contains 12 documents, 148 citations, and an h-index of 7. Together with her multidisciplinary collaborations, these outputs indicate a research portfolio concerned with identifying health determinants and generating evidence relevant to public-health policy and health-system planning. The publications cited in this profile provide the principal basis for evaluating her suitability for recognition through the Best Researcher Award.

Keywords

Rika Rachmalina; medicine; public health; child nutrition; malnutrition; maternal health; health-care access; nutritional disparities; epidemiology; Indonesia; population health; research impact; Best Researcher Award.

Introduction

Research on population health in Indonesia requires consideration of demographic, socioeconomic, nutritional, geographic, and health-system factors. Rachmalina’s documented scholarly contributions address several of these dimensions through observational and population-oriented studies. Her work on child undernutrition, for example, considers variation across Indonesia’s districts, while other studies examine dietary practices among young children and factors associated with access to health care. [1] [2] [4] [6]

The available publication record also demonstrates collaborative research across related areas of medicine and public health. Her authorship on studies concerning child malnutrition, alcohol consumption, hemoglobin levels, and pregnancy complications illustrates an emphasis on identifying measurable health risks and disparities within the Indonesian population. [2] [3] [5] [6]

Research Profile

Rachmalina is associated with the National Research and Innovation Agency in Indonesia and is identified within the medicine subject area. The supplied bibliometric profile reports 12 indexed documents, 148 citations, and an h-index of 7 under Scopus Author ID 57202159129. These indicators provide a quantitative description of the indexed publication record, while the individual publications provide additional context concerning the themes and populations addressed by the research. [1]

  • Primary field: Medicine and public health.
  • Geographic focus: Indonesia and Indonesian population health.
  • Research themes: child nutrition, malnutrition, health disparities, maternal health, health-care access, dietary practices, alcohol consumption, and population health.
  • Reported Scopus documents: 12.
  • Reported citations: 148.
  • Reported h-index: 7.

Research Contributions

A significant component of Rachmalina’s publication record concerns nutritional health among Indonesian children. The 2025 article Factors for minimum acceptable diet practice among 6–23-month-old children in rural and urban areas of Indonesia investigates factors associated with minimum acceptable diet practices among young children across rural and urban settings. The study was published in the Korean Journal of Family Medicine and includes Rachmalina among its contributors. [1]

Her work also includes research on child malnutrition during the COVID-19 pandemic. Published in Pediatric Gastroenterology, Hepatology & Nutrition in 2022, the article addresses the implications of the pandemic for child nutritional conditions in Indonesia and contributes to the broader evidence base concerning vulnerable pediatric populations during periods of health-system disruption. [2]

Publications

  1. Factors for minimum acceptable diet practice among 6–23-month-old children in rural and urban areas of Indonesia. Korean Journal of Family Medicine, 2025. Contributors include Rika Rachmawati, Rika Rachmalina, Yunita Diana Sari, Tri Wurisastuti, Kencana Sari, Ayunina Rizky Ferdina, Noviati Fuada, and Tin Afifah. [1]
  2. Child Malnutrition during the COVID-19 Pandemic in Indonesia. Pediatric Gastroenterology, Hepatology & Nutrition, 2022. Contributors: Lestari Octavia and Rika Rachmalina. [2]
  3. Prevalence Of Indonesia’s Alcohol Consumption, Risk Factors, And Its Cluster Mapping: An Analysis Of Indonesia Basic Health Survey 2018. Gizi Indonesia, 2022. Contributors include Prisca Petty Arfines, Rika Rachmalina, Rofingatul Mubasyiroh, Tities Puspita, and Fuska Atomita Restu Arfines. [3]
  4. Geographic and Socioeconomic Disparity in Child Undernutrition across 514 Districts in Indonesia. Nutrients, 2022. Contributors include Dumilah Ayuningtyas, Dwi Hapsari, Rika Rachmalina, Vilda Amir, Riani Rachmawati, and Dian Kusuma. [4]

Research Impact

The reported bibliometric indicators—12 documents, 148 citations, and an h-index of 7—provide evidence of an established indexed publication record. [1] Beyond these numerical measures, the subject matter of the publications is relevant to public-health questions with direct implications for population-level health assessment. Research addressing child undernutrition across 514 districts, for example, contributes evidence concerning spatial and socioeconomic differences that may be relevant to nutritional planning and resource allocation. [4]

The range of topics represented in the cited publications also indicates interdisciplinary engagement. Nutritional epidemiology, maternal health, health-care accessibility, behavioral risk factors, and population-level biochemical characteristics appear within the documented record. [1] [3] [5] [6]

Award Suitability

The Best Researcher Award recognizes research profiles demonstrating meaningful scholarly activity, documented research output, and contributions to a defined field. Based on the supplied profile, Rachmalina’s work presents several characteristics relevant to such an assessment.

  • Established publication record: The supplied Scopus profile reports 12 documents and 148 citations, with an h-index of 7.
  • Relevant medical research: Her publications address nutrition, child health, maternal health, health-care access, and population-level risk factors.
  • Population-health relevance: Several studies investigate health conditions and disparities affecting Indonesian communities, including children and pregnant women.
  • Collaborative scholarship: The cited publications demonstrate collaboration with researchers from related medical, nutritional, epidemiological, and public-health disciplines.
  • Evidence-oriented research: The publication portfolio uses population and health data to examine determinants and disparities relevant to medical and public-health research.

Conclusion

Rika Rachmalina’s documented research profile is centered on medicine and population health, with a substantial emphasis on nutritional health, child undernutrition, maternal health, health-care access, and health disparities in Indonesia. Her cited publications span 2021 to 2025 and demonstrate continuing engagement with health-related questions of national and population-level relevance. [1] [2] [4] [6] The supplied bibliometric indicators further document an indexed scholarly record of 12 documents, 148 citations, and an h-index of 7. On the basis of these documented research activities, her profile is relevant for consideration in the Best Researcher Award category of the International Popular Scientist Awards.

References

  1. Crossref. (2025). Factors for minimum acceptable diet practice among 6–23-month-old children in rural and urban areas of Indonesia. Korean Journal of Family Medicine.
    https://doi.org/10.4082/kjfm.23.0284
  2. Crossref. (2022). Child Malnutrition during the COVID-19 Pandemic in Indonesia. Pediatric Gastroenterology, Hepatology & Nutrition.
    https://doi.org/10.5223/pghn.2022.25.4.347
  3. Crossref. (2022). Prevalence Of Indonesia’s Alcohol Consumption, Risk Factors, And Its Cluster Mapping: An Analysis Of Indonesia Basic Health Survey 2018. Gizi Indonesia.
  4. Crossref. (2022). Geographic and Socioeconomic Disparity in Child Undernutrition across 514 Districts in Indonesia. Nutrients.
    https://doi.org/10.3390/nu14040843
  5. Crossref. (2021). Perbedaan Kadar Hemoglobin Darah Menurut Karakteristik Dan Frekuensi Konsumsi Tepung Terigu Penduduk Indonesia Umur 10 Tahun Ke Atas. Gizi Indonesia.
  6. Crossref. (2021). Perceived Barriers in Accessing Health Care and the Risk of Pregnancy Complications in Indonesia. International Journal of Women’s Health.
    https://doi.org/10.2147/IJWH.S310850

Fanny Lemarié | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.

Abdel Abdel-Rahman | Cardiovascular Pharmacology | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

Abdel Abdel-Rahman
East Carolina University, United States
Abdel Abdel-Rahman
Affiliation East Carolina University
Country United States
Scopus ID 7102847207
Documents 181
Citations 3711
h-index 33
Subject Area Cardiovascular Pharmacology
Event International Popular Scientist Awards
ORCID
0000-0002-3461-2190

Abdel Abdel-Rahman  the Innovative Research Award recognizes distinguished scientific contributions in the field of cardiovascular pharmacology and related biomedical sciences. Abdel Abdel-Rahman of East Carolina University has developed an extensive scholarly portfolio that reflects sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact in cardiovascular research and pharmacological sciences.[1] His publication record, citation performance, and recognized expertise in cardiovascular pharmacology position him as a notable contributor within the international scientific community.[2]

Abstract

Abdel Abdel-Rahman has contributed extensively to cardiovascular pharmacology through scholarly investigations addressing vascular physiology, autonomic regulation, pharmacodynamics, and therapeutic mechanisms associated with cardiovascular disorders. His academic output demonstrates a strong emphasis on translational biomedical research and pharmacological innovation.[1] With 181 indexed documents, 3711 citations, and an h-index of 33, his work has achieved significant scholarly visibility and international academic engagement.[2] The Innovative Research Award acknowledges these contributions within the framework of the International Popular Scientist Awards program.

Keywords

The Innovative Research Award in Cardiovascular Pharmacology recognizes pioneering contributions that advance the understanding and treatment of cardiovascular diseases through pharmacological innovation and biomedical discovery. This award celebrates researchers whose work bridges Pharmacological Research, Biomedical Sciences, and Translational Medicine to develop safer, more effective cardiovascular therapeutics. It honors excellence in innovative drug development, clinical applications, and transformative scientific research that improves global cardiovascular health outcomes.

Introduction

Cardiovascular pharmacology remains an essential scientific discipline within biomedical research due to its role in understanding cardiovascular diseases, therapeutic mechanisms, and pharmacological interventions. Research within this domain contributes to the development of treatment strategies for hypertension, vascular dysfunction, and cardiac pathophysiology.[2]

Abdel Abdel-Rahman has maintained a sustained academic presence in this field through research activities associated with East Carolina University. His work demonstrates consistent scholarly productivity and scientific engagement within cardiovascular and pharmacological sciences.[1] The International Popular Scientist Awards recognize researchers whose scientific achievements contribute meaningfully to academic advancement and interdisciplinary biomedical knowledge.

Research Profile

The research profile of Abdel Abdel-Rahman reflects extensive engagement in cardiovascular pharmacology, autonomic regulation, neuropharmacology, and vascular function research. His scientific investigations have addressed mechanisms influencing blood pressure regulation, pharmacological responses, and cardiovascular signaling pathways.[2]

Bibliometric indicators associated with his scholarly output demonstrate sustained academic visibility. According to indexed scholarly databases, his work has accumulated thousands of citations and a notable h-index, indicating both productivity and citation influence within the biomedical research community.[2]

Research Contributions

Abdel Abdel-Rahman’s scientific contributions include investigations into cardiovascular regulation, pharmacological interactions, and neurovascular signaling. His studies have explored physiological mechanisms underlying vascular control and the pharmacodynamics associated with cardiovascular therapeutics.[5]

Several publications associated with his research profile have examined experimental pharmacological models relevant to cardiovascular disease mechanisms and therapeutic responses. These contributions have enhanced understanding of autonomic modulation and vascular pharmacology within preclinical and translational research contexts.[1]

Publications

The publication portfolio of Abdel Abdel-Rahman includes peer-reviewed articles focusing on cardiovascular pharmacology and related biomedical sciences. His indexed research output demonstrates continuity in scientific productivity and interdisciplinary collaboration.[1]

Representative publications indexed within international scholarly databases have contributed to citation growth and broader academic dissemination.[2]

Research Impact

The scientific impact of Abdel Abdel-Rahman’s work is reflected through citation metrics, publication visibility, and continued relevance within cardiovascular pharmacology research. His research output has contributed to ongoing academic discussions concerning cardiovascular physiology, vascular pharmacology, and therapeutic intervention strategies.

An h-index of 33 indicates consistent citation performance across multiple scholarly works, while a citation count exceeding 3700 demonstrates sustained engagement by the international biomedical research community.[2] These indicators collectively support the scholarly significance of his research activities.

Award Suitability

The Innovative Research Award recognizes individuals demonstrating substantial scientific contributions, scholarly influence, and research advancement within their respective disciplines. Abdel Abdel-Rahman’s academic profile aligns with these criteria through sustained publication activity, recognized citation impact, and research contributions within cardiovascular pharmacology.[1]

His scientific work reflects methodological rigor, interdisciplinary relevance, and ongoing contributions to pharmacological sciences. Participation in the International Popular Scientist Awards further highlights the importance of promoting impactful biomedical research and academic excellence.[1]

Conclusion

Abdel Abdel-Rahman’s scholarly record demonstrates a sustained commitment to cardiovascular pharmacology and biomedical research. Through extensive publication activity, measurable citation influence, and interdisciplinary scientific contributions, he has established a recognized academic presence within the international research community.[2] The Innovative Research Award acknowledges these accomplishments within the broader context of scientific advancement and research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Abdel Abdel-Rahman, Author ID 7102847207. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102847207
  2. ORCID. (n.d.). ORCID profile for Abdel Abdel-Rahman.
    https://orcid.org/0000-0002-3461-2190
  3. International Popular Scientist Awards. (n.d.). Research recognition and scientific excellence initiatives.
    https://popularscientist.com/
  4. Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill Education

Shubana Hayat | Medicine | Research Excellence Award

Published on by International Popular Scientist Awards

Ms. Shubana Hayat | Medicine | Research Excellence Award

University of Campania | Italy

Ms. Shubana Hayat is a microbiology researcher with expertise in microbial isolation, characterization, and antimicrobial analysis, focusing on environmental and public health microbiology. Her research explores antimicrobial activities of medicinal plants, microbial contamination in water sources, and bacterial resistance patterns, contributing to sustainable health and sanitation solutions. She has experience in academic teaching, laboratory research assistance, and clinical microbiology practices. Her technical proficiency includes molecular techniques, microbiological assays, and bio-burden analysis. With 24 citations across 7 documents, and an h-index of 2, her work supports advancements in microbiological research, food safety, and environmental sustainability.

Citation Metrics (Scopus)

24

18

12

6

0

Citations
24

Documents
7

h-index
2

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Federica Tonon | Medicine | Research Excellence Distinction Award

Published on by International Popular Scientist Awards

Dr. Federica Tonon | Medicine | Research Excellence Distinction Award

Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) | Italy 

Dr. Federica Tonon is a biomedical researcher specializing in molecular biology, translational medicine, and clinical data science, with research focusing on cancer biology, hepatocellular carcinoma, endocrine pathways, and the renin–angiotensin system. Her work integrates advanced experimental models including zebrafish, murine systems, and stem cell technologies to investigate disease mechanisms, biomarkers, and therapeutic strategies. She has contributed to interdisciplinary projects combining laboratory research and clinical data management, supporting precision medicine approaches. Her scholarly impact includes 845 citations across 748 documents, with 38 Document and an h-index of 17, reflecting sustained contributions to biomedical research, innovation, and scientific advancement.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
845

Documents
38

h-index
17

🟦 Citations 🟥 Documents 🟩 h-index


View Scopus Profile
    View Orcid Profile

Featured Publications

Konduru Balakrishna | Molecular Diagnostics | Industry Impact Award

Published on by International Popular Scientist Awards

Dr. Konduru Balakrishna | Molecular Diagnostics | Industry Impact Award

Scientist | Defence Institute of Biodefence Technologies | India

Dr. Konduru Balakrishna is a senior scientist with extensive expertise in food microbiology, molecular biotechnology, and biodefence-related diagnostics. His research focuses on rapid detection of foodborne and zoonotic pathogens, mycotoxins, and biological threat agents using molecular, immunological, and recombinant protein–based approaches. He has made significant contributions to multiplex PCR assays, monoclonal antibody development, chimeric proteins, and vaccine candidates for bacterial infections. His work bridges fundamental microbiology and applied biosensing, leading to multiple granted patents and high-impact publications. His research output includes 31 documents, cited 474 times, with an h-index of 13, reflecting his role in advancing indigenous technologies for food safety, public health protection, and biodefence applications through translational research and innovation.

Citation Metrics (Scopus)

600

450
300
150
0

Citations
474

Documents
31

h-index
13

🟦 Citations   🟥 Documents   🟩 h-index


View Scopus Profile

Featured Publications

Quan Zhang | Pharmaceutics | Research Excellence Award

Published on by International Popular Scientist Awards

Dr. Quan Zhang | Pharmaceutics | Research Excellence Award

Chengdu Medical College | China

Dr. Quan Zhang is an accomplished pharmaceutical scientist recognized for his contributions to targeted drug delivery and drugability optimization. His research focuses on developing advanced delivery platforms for tumor immunotherapy, brain disorders, and arthritis, along with improving the pharmacokinetic and therapeutic profiles of polyphenolic compounds and traditional Chinese medicine formulations. He has led numerous competitive research projects, including national-level grants and industry collaborations, and has played a key role in advancing both basic and applied pharmaceutical studies. His work has resulted in a substantial body of high-impact publications, several invention patents, and contributions to academic textbooks. Dr. Zhang has made notable advances in biomimetic nanomedicine, tumor microenvironment–responsive therapeutics, and innovative formulations for alcohol intoxication management, including the discovery of novel active compounds and the development of commercial health products. His research outcomes have influenced the fields of cancer therapy, neurodegenerative disease treatment, and anti-inflammatory drug strategies, integrating molecular design with translational pharmaceutical technology. He has been recognized through talent programs and scientific awards, reflecting his leadership in pharmaceutics and his impact on interdisciplinary drug research.

Profile: Scopus

Featured Publications

Zhang, Q., et al. (2024). Current advances in biomimetic drug delivery system for targeted therapy of rheumatoid arthritis. Acta Pharmaceutica Sinica B.

Zhang, Q., et al. (2024). Co-delivery nanoparticle targeting CAF for simultaneous activating T cell plus NK cell attack in solid tumor. Journal of Controlled Release.

Deng, C., Zhang, Q., Jia, M., Zhao, J., Sun, X., Gong, T., & Zhang, Z. (2019). Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer. Advanced Science, 6, 1801868.

Deng, C., Zhang, Q., He, P., Zhou, B., He, K., Sun, X., Lei, G., Gong, T., & Zhang, Z. (2021). Targeted apoptosis of macrophages and osteoclasts in arthritic joints is effective against advanced inflammatory arthritis. Nature Communications, 12, 2174.

Mao, J., Liu, X., Zhang, L., Chen, Y., Zhou, S., Liu, Y., Ye, J., Xu, X., & Zhang, Q. (2024). Self-nanoemulsifying drug delivery system of morin: A new approach for combating acute alcohol intoxication. International Journal of Nanomedicine, 19, 10569–10588.

Amirreza Keyvanfar | Infectious diseases | Editorial Board Member

Published on by International Popular Scientist Awards

Dr. Amirreza Keyvanfar | Infectious diseases | Editorial Board Member

Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran | Iran

Dr. Amirreza Keyvanfar is a medical researcher with an MD-MPH background whose work integrates clinical insight with cellular and molecular scientific approaches to advance understanding of infectious and tropical diseases. His research interests span disease pathogenesis, diagnostic innovation, therapeutic response assessment, epidemiology, and surveillance, with particular emphasis on linking biological mechanisms to clinical outcomes. He has developed strong expertise in scientific writing, research methodology, study design, biostatistics, and data analysis using platforms such as PRISM, SPSS, R, and STATA. His early achievements in competitive biology inspired a sustained commitment to exploring the molecular foundations of human disease, a pursuit strengthened through rigorous medical and public health training. Dr. Keyvanfar’s work bridges clinical and laboratory sciences, contributing publications derived from aligning patient characteristics with emerging evidence. In addition to his experience in clinical research, he possesses hands-on proficiency in core laboratory techniques, including gene extraction, PCR, gel documentation, blotting, electrophoresis, ELISA, hemagglutination assays, chromatography, microbiological culture, and spectrophotometry, enabling him to investigate disease mechanisms across multiple scales. His research philosophy centers on integrating practical clinical problem-solving with robust analytical and molecular methods to generate meaningful insights that improve diagnostic accuracy, therapeutic strategies, and public health decision-making. Through his role in infectious disease research, he continues to contribute to multidisciplinary efforts aimed at understanding emerging health threats and enhancing evidence-based approaches to disease prevention and management.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Najafiarab, H., Farzaneh, F., Keyvanfar, A., & Talebian, N. (2025). Application of amniotic membrane to effectively treat chronic cervicitis: A case series. Cell Journal (Yakhteh).

Yadegarynia, D., Keyvanfar, A., Keramati, A., Najafiarab, H., Norouzi, S., Soleimani, S., Bodaghi, A., Arshi, S., Tehrani, S., Sharafi, F., et al. (2025). A national report on 2024 dengue fever outbreak in Iran: Has the game changed? BMC Infectious Diseases.

Mardani, M., Keyvanfar, A., & Mardani, S. (2025). Measles resurgence in Iran: A preventable public health crisis. Archives of Clinical Infectious Diseases.

Abolghasemi, S., Ghazi, M., Ziaie, S., Mahboubi, A., Gachkar, L., Keyvanfar, A., & Naeimipoor, M. (2025).

Comparison of the efficacy of povidone-iodine with mupirocin in decolonizing Staphylococcus aureus from the nasal cavity of healthcare workers: A single-blinded randomized controlled trial. Infectious Disorders – Drug Targets.

Iacopo Cappellini | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Dr. Iacopo Cappellini | Medicine | Best Researcher Award

  University of Florence, Italy

Dr. Iacopo Cappellini  is an experienced Consultant in Anesthesia and Intensive Care with a strong academic and clinical background in critical care medicine. He currently serves in a mixed medical-surgical ICU, with expertise in robotic and laparoscopic surgeries across multiple specialties, including cardiovascular and thoracic anesthesia, organ transplantation, and trauma care.

Profile:

Academic & Research Background:

  • PhD in Anesthesia and Surgical Sciences, University of Florence (2018)
    Thesis: “Diaphragmatic function in Anesthesia and ICU: Role of ultrasonography in assessing postoperative residual curarization”

  • II Level Master’s in Epidemiology and Biostatistics, University of Milano-Bicocca (2021)

  • Over 30 peer-reviewed publications in high-impact journals (PubMed indexed)

  • Co-investigator and author in multiple studies on ECMO, diaphragm ultrasonography, mechanical ventilation, COVID-19 ARDS, and REBOA

  • Visiting Fellowships and Research Appointments in:

    • University of Illinois Chicago

    • Brown University

    • Monash University

    • Mount Sinai Hospital, NY

Key Clinical Experience:

  • Consultant in mixed ICUs (20 beds), advanced anesthesia for:

    • Robotic GI, thoracic, ENT, orthopedic, urology, pediatric surgeries

    • Cardiovascular & thoracic procedures, heart/lung transplants (adult and pediatric)

  • Extensive procedural skills: regional blocks, ECMO/ECCOR, EIT, advanced airway management, echocardiography

  • Emergency Medical Doctor for EMS (Prehospital trauma and ACLS scenarios)

  • Involved in regional organ donation (DBD) protocol development in Tuscany

Publications & Contributions:

  • Over 30 scientific articles including:

    • Anesthesia Research (MDPI), Emergency Care Journal, BMJ Open, Methods and Protocols, Frontiers in Medicine, European Journal of Anesthesiology

  • Recent titles:

    • “Assessment of Visual Function in Patients Undergoing Prone Positioning for COVID-19 ARDS” (2025)

    • “Electrical Impedance Tomography and AI in Respiratory Monitoring” (2024)

    • “Dehumanization in ICUs vs Standard Wards: A Cross-sectional Study” (2024)

  • Contributor to international COVID-19 ICU collaborations (ICU-RER Network)

Certifications & Training:

  • ACLS, PALS, ATLS, ITLS, ABLS, NALS, EPLS certified

  • European Society of Anesthesiology: EDAIC certified

  • Trained in critical care ultrasonography, advanced life support, trauma management

  • Regular faculty for academic anesthesia courses at the University of Florence

Honors and Awards:

  • 🏅 Best Scientific Contribution, 66th National SIAARTI Congress (2012) – for research on KPC outbreak in ICU settings

Technical Proficiency:

  • R, RStudio (biostatistics, machine learning in clinical research)

  • Familiarity with Python ML libraries (scikit-learn, TensorFlow)

  • MS Office, academic databases, CRO collaboration experience

Professional Affiliations:

  • SIAARTI (Italy), ESA (Europe), GMC (UK)

  • Collaborator with Clinical Research Organizations in observational studies (septic shock, ICU outcomes)

Citation Metrics Summary:

  • Total Citations: 467

  • Citing Documents: 448

  • Total Publications: 25

  • h-index: 12

Publication Top Notes:

1. Status of Sepsis Care in European Hospitals: Results from an International Cross-Sectional Survey
American Journal of Respiratory and Critical Care Medicine, 2025
Citations: 2 | Article Type: Review | Access: Open Access

2. Electrical Impedance Tomography, Artificial Intelligence, and Variable Ventilation: Transforming Respiratory Monitoring and Treatment in Critical Care
Journal Name Not Specified, 2025
Citations: 5 | Article Type: Review | Access: Open Access

 

Deepak Kumar Dogra | Health | Best Researcher Award

Published on by International Popular Scientist Awards

Dr. Deepak Kumar Dogra | Health | Best Researcher Award

Assistant Professor at Department Of Physical Education, BHU, India

Dr. Deepak Kumar Dogra is an Assistant Professor in the Department of Physical Education at Banaras Hindu University (BHU), Varanasi, Uttar Pradesh. He holds a Master’s degree in Physical Education and Sports Sciences from I.G.I.P.E.S.S., University of Delhi (1999), and earned his Ph.D. in the same field from D.A.V.V., Indore, Madhya Pradesh (2013).

Profile:

🎓 Academic Background:

Dr. Deepak Kumar Dogra holds a Master’s degree in Physical Education and Sports Sciences from I.G.I.P.E.S.S., University of Delhi (1999), and earned his Ph.D. in the same field from Devi Ahilya Vishwavidyalaya (DAVV), Indore (2013).

🏛️ Current Position:

He is currently serving as an Assistant Professor in the Department of Physical Education at Banaras Hindu University (BHU), Varanasi, Uttar Pradesh.

🧘‍♂️ Research & Specialization:

With a specialization in alternative and rehabilitation physical exercise therapy, Dr. Dogra focuses on improving health, wellness, and quality of life through sports and physical activity.

📚 Academic Engagements:

He has been invited as a resource person in numerous:

  • Faculty Development Programs (FDPs)

  • Orientation programs and workshops by UGC, HRDC, NCERT

  • Sports training sessions by Rajasthan Cricket Association and Tripura Cricket Association (affiliated with BCCI)

  • Programs of the Ministry of Youth Affairs and Sports, Govt. of Jharkhand.

🌍 Seminars & Publications:

He has contributed to national and international seminars and has published several research articles in reputed indexed journals in his domain.

🏏 Sports & Fitness Involvement:

Dr. Dogra served as a Trainer for:

  • East Zone Senior Cricket Team (Deodhar Trophy 2008–09, Runners-Up)

  • Tripura Senior Cricket Team (Ranji Trophy & Vijay Hazare Trophy: 2007–09)

🏋️ Industry Experience:

He worked as a Corporate Fitness Consultant at VLCC Pvt. Ltd. (2000–2005), showcasing a strong link between academia and the wellness industry.

Publication Top Notes:

  • A Comparative Study on the Viewership of Different Professional Leagues in India
    International Sports Law Journal, 2023
    DOI: 10.1007/s40318-023-00243-8
    Co-authors: Shukla, A., Dogra, D.K., Bhattacharya, D., Gulia, S., Sharma, R.

  • Impact of COVID-19 Outbreak on the Mental Health in Sports: A Review
    Sport Sciences for Health, 2023
    DOI: 10.1007/s11332-023-01063-x
    Co-authors: Shukla, A., Dogra, D.K., Bhattacharya, D., Gulia, S., Sharma, R.

  • Effect of Exercise Intervention on Selected Psychological Variables: A Systematic Review
    Journal of Positive School Psychology, June 2022
    ISSN: 2717-7564
    Sole Author: Dr. Deepak Kumar Dogra

  • Effect of Aerobic Exercise Interventions on Body Composition in Obese Females
    International Journal of Health Sciences, 17 June 2022
    DOI: 10.53730/ijhs.v6ns3.9140
    Co-authors: Deepak Kumar Dogra, Debraj Bhatacharjee, Akash Shukla

  • Issues of Hosting Mega Sporting Events
    6th National Conference on Physical Education & Sports Sciences, March 2022
    ISSN: 2279-0306
    Author: Dr. Deepak Kumar Dogra

  • A Comparative Study of Physical Fitness Variables Between Different Academia Intercollegiate Sportsmen
    Journal of Critical Reviews, 14 July 2020
    ISSN: 2394-5125
    Author: Dr. Deepak Kumar Dogra

  • Comparative Study on Selected Physical Fitness Variables Among Different Team Games Players
    International Journal of Physical Education, Sports and Health, 25 February 2020
    ISSN: 2394-1693
    Author: Dr. Deepak Kumar Dogra